US Stock MarketDetailed Quotes

OM Outset Medical

Watchlist
  • 0.610
  • +0.040+7.02%
Close Nov 1 16:00 ET
31.77MMarket Cap-194P/E (TTM)

Outset Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-24.01%27.39M
-15.83%28.17M
13.00%130.38M
-4.69%30.51M
9.37%30.36M
43.83%36.04M
9.55%33.47M
12.45%115.38M
13.69%32.01M
5.48%27.76M
Operating revenue
-24.01%27.39M
-15.83%28.17M
13.00%130.38M
-4.69%30.51M
9.37%30.36M
43.83%36.04M
9.55%33.47M
12.45%115.38M
13.69%32.01M
5.48%27.76M
Cost of revenue
-37.87%17.61M
-26.21%19.95M
3.93%101.38M
-14.73%22.8M
-0.94%23.21M
33.19%28.34M
3.57%27.04M
2.68%97.54M
7.66%26.73M
0.23%23.43M
Gross profit
26.99%9.78M
27.80%8.22M
62.62%29M
46.25%7.71M
65.06%7.16M
103.68%7.7M
44.71%6.43M
134.40%17.83M
58.78%5.27M
47.18%4.34M
Operating expense
-20.78%40.55M
-9.59%45.13M
11.14%198.77M
-0.07%45.07M
16.05%52.61M
7.74%51.18M
21.99%49.91M
29.48%178.85M
2.21%45.1M
37.03%45.34M
Selling and administrative expenses
-15.06%30.81M
-10.04%32.49M
8.82%141.46M
-3.33%32.53M
13.20%36.54M
6.75%36.28M
20.06%36.12M
28.22%130M
2.88%33.65M
38.20%32.28M
-Selling and marketing expense
-27.44%18.13M
-13.50%21.05M
7.54%96.23M
-6.08%22.19M
10.97%24.72M
7.70%24.99M
19.41%24.33M
37.52%89.48M
2.78%23.63M
41.65%22.28M
-General and administrative expense
12.35%12.68M
-2.91%11.44M
11.64%45.23M
3.16%10.34M
18.15%11.82M
4.69%11.29M
21.40%11.79M
11.56%40.52M
3.12%10.02M
31.08%10M
Research and development costs
-34.70%9.73M
-8.40%12.64M
17.30%57.31M
9.51%12.53M
23.10%16.08M
10.24%14.91M
27.35%13.79M
32.97%48.86M
0.30%11.44M
34.23%13.06M
Operating profit
29.24%-30.76M
15.12%-36.91M
-5.43%-169.77M
6.20%-37.35M
-10.87%-45.45M
0.56%-43.48M
-19.22%-43.49M
-23.37%-161.02M
2.39%-39.82M
-36.04%-41M
Net non-operating interest income expense
-713.56%-3.54M
-876.19%-2.87M
-810.55%-2.5M
-500.53%-1.14M
-368.91%-640K
-1,877.27%-435K
2.65%-294K
77.40%-275K
38.64%-189K
171.69%238K
Non-operating interest income
-7.38%2.47M
16.99%3.1M
209.05%10.17M
19.66%2.28M
219.63%2.57M
481.26%2.67M
2,106.67%2.65M
560.84%3.29M
1,450.41%1.91M
713.13%805K
Non-operating interest expense
93.68%6.01M
102.86%5.97M
255.44%12.68M
63.02%3.42M
466.67%3.21M
545.11%3.1M
597.16%2.94M
107.93%3.57M
386.31%2.1M
31.55%567K
Other net income (expense)
-1.37M
Special income (charges)
----
----
--0
----
----
----
----
---1.37M
----
----
-Less:Other special charges
----
----
----
----
----
----
----
--1.37M
----
----
Income before tax
21.88%-34.3M
9.13%-39.78M
-5.91%-172.27M
6.99%-38.49M
-13.08%-46.09M
-0.39%-43.91M
-19.04%-43.78M
-23.47%-162.66M
-0.66%-41.38M
-33.77%-40.76M
Income tax
13.53%151K
-15.63%162K
77.29%523K
75.00%112K
330.00%86K
38.54%133K
66.96%192K
48.24%295K
-48.80%64K
20K
Net income
21.78%-34.45M
9.16%-39.94M
-6.04%-172.8M
6.86%-38.6M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-23.51%-162.96M
-0.51%-41.44M
-33.84%-40.78M
Net income continuous Operations
21.78%-34.45M
9.16%-39.94M
-6.04%-172.8M
6.86%-38.6M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-23.51%-162.96M
-0.51%-41.44M
-33.84%-40.78M
Minority interest income
Net income attributable to the parent company
21.78%-34.45M
9.16%-39.94M
-6.04%-172.8M
6.86%-38.6M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-23.51%-162.96M
-0.51%-41.44M
-33.84%-40.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.78%-34.45M
9.16%-39.94M
-6.04%-172.8M
6.86%-38.6M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-23.51%-162.96M
-0.51%-41.44M
-33.84%-40.78M
Basic earnings per share
26.67%-0.66
13.33%-0.78
-2.96%-3.48
10.47%-0.77
-9.41%-0.93
2.17%-0.9
-15.38%-0.9
-16.96%-3.38
1.15%-0.86
-30.77%-0.85
Diluted earnings per share
26.67%-0.66
13.33%-0.78
-2.96%-3.48
10.47%-0.77
-9.41%-0.93
2.17%-0.9
-15.38%-0.9
-16.96%-3.38
1.15%-0.86
-30.77%-0.85
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -24.01%27.39M-15.83%28.17M13.00%130.38M-4.69%30.51M9.37%30.36M43.83%36.04M9.55%33.47M12.45%115.38M13.69%32.01M5.48%27.76M
Operating revenue -24.01%27.39M-15.83%28.17M13.00%130.38M-4.69%30.51M9.37%30.36M43.83%36.04M9.55%33.47M12.45%115.38M13.69%32.01M5.48%27.76M
Cost of revenue -37.87%17.61M-26.21%19.95M3.93%101.38M-14.73%22.8M-0.94%23.21M33.19%28.34M3.57%27.04M2.68%97.54M7.66%26.73M0.23%23.43M
Gross profit 26.99%9.78M27.80%8.22M62.62%29M46.25%7.71M65.06%7.16M103.68%7.7M44.71%6.43M134.40%17.83M58.78%5.27M47.18%4.34M
Operating expense -20.78%40.55M-9.59%45.13M11.14%198.77M-0.07%45.07M16.05%52.61M7.74%51.18M21.99%49.91M29.48%178.85M2.21%45.1M37.03%45.34M
Selling and administrative expenses -15.06%30.81M-10.04%32.49M8.82%141.46M-3.33%32.53M13.20%36.54M6.75%36.28M20.06%36.12M28.22%130M2.88%33.65M38.20%32.28M
-Selling and marketing expense -27.44%18.13M-13.50%21.05M7.54%96.23M-6.08%22.19M10.97%24.72M7.70%24.99M19.41%24.33M37.52%89.48M2.78%23.63M41.65%22.28M
-General and administrative expense 12.35%12.68M-2.91%11.44M11.64%45.23M3.16%10.34M18.15%11.82M4.69%11.29M21.40%11.79M11.56%40.52M3.12%10.02M31.08%10M
Research and development costs -34.70%9.73M-8.40%12.64M17.30%57.31M9.51%12.53M23.10%16.08M10.24%14.91M27.35%13.79M32.97%48.86M0.30%11.44M34.23%13.06M
Operating profit 29.24%-30.76M15.12%-36.91M-5.43%-169.77M6.20%-37.35M-10.87%-45.45M0.56%-43.48M-19.22%-43.49M-23.37%-161.02M2.39%-39.82M-36.04%-41M
Net non-operating interest income expense -713.56%-3.54M-876.19%-2.87M-810.55%-2.5M-500.53%-1.14M-368.91%-640K-1,877.27%-435K2.65%-294K77.40%-275K38.64%-189K171.69%238K
Non-operating interest income -7.38%2.47M16.99%3.1M209.05%10.17M19.66%2.28M219.63%2.57M481.26%2.67M2,106.67%2.65M560.84%3.29M1,450.41%1.91M713.13%805K
Non-operating interest expense 93.68%6.01M102.86%5.97M255.44%12.68M63.02%3.42M466.67%3.21M545.11%3.1M597.16%2.94M107.93%3.57M386.31%2.1M31.55%567K
Other net income (expense) -1.37M
Special income (charges) ----------0-------------------1.37M--------
-Less:Other special charges ------------------------------1.37M--------
Income before tax 21.88%-34.3M9.13%-39.78M-5.91%-172.27M6.99%-38.49M-13.08%-46.09M-0.39%-43.91M-19.04%-43.78M-23.47%-162.66M-0.66%-41.38M-33.77%-40.76M
Income tax 13.53%151K-15.63%162K77.29%523K75.00%112K330.00%86K38.54%133K66.96%192K48.24%295K-48.80%64K20K
Net income 21.78%-34.45M9.16%-39.94M-6.04%-172.8M6.86%-38.6M-13.24%-46.18M-0.47%-44.05M-19.19%-43.97M-23.51%-162.96M-0.51%-41.44M-33.84%-40.78M
Net income continuous Operations 21.78%-34.45M9.16%-39.94M-6.04%-172.8M6.86%-38.6M-13.24%-46.18M-0.47%-44.05M-19.19%-43.97M-23.51%-162.96M-0.51%-41.44M-33.84%-40.78M
Minority interest income
Net income attributable to the parent company 21.78%-34.45M9.16%-39.94M-6.04%-172.8M6.86%-38.6M-13.24%-46.18M-0.47%-44.05M-19.19%-43.97M-23.51%-162.96M-0.51%-41.44M-33.84%-40.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.78%-34.45M9.16%-39.94M-6.04%-172.8M6.86%-38.6M-13.24%-46.18M-0.47%-44.05M-19.19%-43.97M-23.51%-162.96M-0.51%-41.44M-33.84%-40.78M
Basic earnings per share 26.67%-0.6613.33%-0.78-2.96%-3.4810.47%-0.77-9.41%-0.932.17%-0.9-15.38%-0.9-16.96%-3.381.15%-0.86-30.77%-0.85
Diluted earnings per share 26.67%-0.6613.33%-0.78-2.96%-3.4810.47%-0.77-9.41%-0.932.17%-0.9-15.38%-0.9-16.96%-3.381.15%-0.86-30.77%-0.85
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data